These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21093952)

  • 1. Influenza vaccine for healthy adult workers: an issue for health authorities or employers?
    Garattini L; Koleva D
    Health Policy; 2011 Sep; 102(1):89-95. PubMed ID: 21093952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of vaccination against influenza in healthy, working adults.
    Nichol KL; Lind A; Margolis KL; Murdoch M; McFadden R; Hauge M; Magnan S; Drake M
    N Engl J Med; 1995 Oct; 333(14):889-93. PubMed ID: 7666874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influenza vaccination of hospital healthcare staff from the perspective of the employer: a positive balance].
    Hak E; Knol LM; Wilschut JC; Postma MJ
    Ned Tijdschr Geneeskd; 2010; 154():A1188. PubMed ID: 20977784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccination in healthy working adults in Russia: observational study of effectiveness and return on investment for the employer.
    At'kov OY; Azarov AV; Zhukov DA; Nicoloyannis N; Durand L
    Appl Health Econ Health Policy; 2011 Mar; 9(2):89-99. PubMed ID: 21332253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of efficacy and economic impact of an influenza vaccination campaign in the personnel of a health care setting].
    Cella MT; Corona G; Tuccillo E; Franco G
    Med Lav; 2005; 96(6):483-9. PubMed ID: 16983973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A worksite influenza immunization program. Impact on lost work days, health care utilization, and health care spending.
    Dille JH
    AAOHN J; 1999 Jul; 47(7):301-9. PubMed ID: 10661043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influenza vaccination of nurses in an Italian pediatric hospital: effects on absenteeism and on costs, factors associated with vaccine uptake and analysis of personal motivations. A prospective cohort study].
    Festini F; Biermann KP; Neri S; Reali MF; de Martino M
    Assist Inferm Ric; 2007; 26(1):5-13. PubMed ID: 17489334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
    Rothberg MB; Rose DN
    Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of vaccination against influenza among working people--results of epidemiological studies].
    Hanke W
    Med Pr; 2000; 51(5):475-84. PubMed ID: 11199177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of influenza vaccination in working-age cancer patients.
    Avritscher EB; Cooksley CD; Geraci JM; Bekele BN; Cantor SB; Rolston KV; Elting LS
    Cancer; 2007 Jun; 109(11):2357-64. PubMed ID: 17457827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.
    Aballéa S; Chancellor J; Martin M; Wutzler P; Carrat F; Gasparini R; Toniolo-Neto J; Drummond M; Weinstein M
    Value Health; 2007; 10(2):98-116. PubMed ID: 17391419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of influenza vaccination: a survey within the Italian Ministry of Health personnel.
    Rizzuto E; Prete AM; Virtuani L; Pompa MG
    Vaccine; 2006 Nov; 24(44-46):6612-4. PubMed ID: 16997434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.
    Postma MJ; Jansema P; van Genugten ML; Heijnen ML; Jager JC; de Jong-van den Berg LT
    Drugs; 2002; 62(7):1013-24. PubMed ID: 11985488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons.
    Szucs TD; Müller D
    Vaccine; 2005 Oct; 23(43):5055-63. PubMed ID: 16046035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50-64 years.
    Nichol KL; D'Heilly SJ; Greenberg ME; Ehlinger E
    Clin Infect Dis; 2009 Feb; 48(3):292-8. PubMed ID: 19115970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scenarios on costs and savings of influenza treatment and prevention for Dutch healthy working adults.
    Postma MJ; Jansema P; Scheijbeler HW; van Genugten ML
    Vaccine; 2005 Nov; 23(46-47):5365-71. PubMed ID: 16029916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of influenza vaccination of healthy children.
    Salo H; Kilpi T; Sintonen H; Linna M; Peltola V; Heikkinen T
    Vaccine; 2006 Jun; 24(23):4934-41. PubMed ID: 16678945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.